Thomas J. Schuetz
2023
In 2023, Thomas J. Schuetz earned a total compensation of $4.9M as President of Research & Development formerly CEO at Compass Therapeutics, a 130% increase compared to previous year.
Compensation breakdown
| Bonus | $244,375 |
|---|---|
| Option Awards | $2,072,331 |
| Salary | $575,000 |
| Stock Awards | $1,965,000 |
| Other | $16,500 |
| Total | $4,873,206 |
Schuetz received $2.1M in option awards, accounting for 43% of the total pay in 2023.
Schuetz also received $244.4K in bonus, $575K in salary, $2M in stock awards and $16.5K in other compensation.
Rankings
In 2023, Thomas J. Schuetz's compensation ranked 126th out of 3,006 executives tracked by ExecPay. In other words, Schuetz earned more than 95.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 126 out of 3,006 | 96th |
Division Manufacturing | 67 out of 1,650 | 96th |
Major group Chemicals And Allied Products | 40 out of 918 | 96th |
Industry group Drugs | 39 out of 881 | 96th |
Industry Biological Products, Except Diagnostic Substances | 13 out of 213 | 94th |
Source: SEC filing on April 29, 2024.
Schuetz's colleagues
We found one more compensation record of an executive who worked with Thomas J. Schuetz at Compass Therapeutics in 2023.
2023
Vered Bisker-Leib
Compass Therapeutics